Health care stocks fell Thursday afternoon, with the NYSE Health Care Index easing 0.1% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.3%.
The iShares Biotechnology ETF (IBB) rose 0.2%.
In corporate news, NRX Pharmaceuticals (NRXP) shares surged 38%. The Hope Therapeutics unit plans to acquire the Kadima Neuropsychiatry Institute.
Avalo Therapeutics (AVTX) shares jumped 14. Jennifer Riley was appointed to the newly created role of chief strategy officer.
Neumora Therapeutics (NMRA) shares plunged 82% after a phase 3 trial of navacaprant to treat major depressive disorder failed to meet the primary endpoint.